$HSIC (Henry Schein, Inc.)

$HSIC {{ '2016-05-25T18:00:21+0000' | timeago}} • SEC

During 1Q16, $HSIC said it wrote off about $1.1MM of fully reserved accounts receivable against its trade receivable reserve. The company also said its inventory turns from operations fell to 5.1 as of March 26, 2016 from 5.3 as of March 28, 2015.

$HSIC {{ '2018-01-08T14:30:38+0000' | timeago}} • Announcement

$HSIC has acquired a 60% ownership investment in ABASE, a family-owned distributor of veterinary health care products in Brazil. ABASE had 2017 revenues of approx. $27MM. $HSIC expects the transaction to be neutral to its 2018 EPS and to be accretive thereafter. Financial terms were not disclosed.

$HSIC {{ '2017-12-18T13:19:44+0000' | timeago}} • Announcement

$HSIC acquired eVetPractice, a provider of cloud-based practice management solutions to veterinary clinics. eVetPractice will join Henry Schein Veterinary Solutions (HSVS), the global leader in veterinary technology solutions, and become the newest addition to its expanding software portfolio.

$HSIC {{ '2017-11-06T15:26:38+0000' | timeago}} • Infographic

$HSIC Henry Schein Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$HSIC {{ '2017-11-06T14:11:50+0000' | timeago}} • Announcement

$HSIC expects 2018 EPS to be $3.85-3.96. This forecast reflects growth of 11-14% compared with the midpoint of its 2017 GAAP forecast range and growth of 7-10% compared to the midpoint of its 2017 non-GAAP estimate range. The guidance is for current continuing operations as well as completed or prior acquisitions.

$HSIC {{ '2017-11-06T14:09:18+0000' | timeago}} • Announcement

$HSIC lowered its 2017 EPS guidance to $3.46-3.48 from $3.57-3.63. The revised EPS forecast reflects growth of about 12% compared to 2016 EPS of $3.10. The company narrowed its 2017 non-GAAP EPS outlook to $3.59-3.61 from $3.59-3.65. The adjusted estimate reflects 8-9% growth compared to 2016 non-GAAP EPS of $3.31.

$HSIC {{ '2017-11-06T14:05:27+0000' | timeago}} • Announcement

$HSIC reported a 3.2% rise in 3Q17 earnings on higher sales, despite recent hurricanes and difficult comparable in dental equipment sales. Net income rose to $138MM or $0.87 per share from $133.7MM or $0.82 per share last year. Sales grew 10.3% to $3.2Bil, on continued products offering success and value-added services that drive internal growth.

$HSIC {{ '2017-10-16T21:12:57+0000' | timeago}} • Announcement

$HSIC's Emergency Medical Services (EMS) business has entered an exclusive agreement with Terason to distribute uSmart 3200T NexGen, a portable ultrasound device that enables emergency responders to perform exams in emergency medical transport vehicles and aircrafts.

$HSIC {{ '2017-10-10T13:14:42+0000' | timeago}} • Announcement

$HSIC completed the acquisition of Merritt Veterinary Supplies, family-owned supplier of animal health products. $HSIC expects the  acquisition to be neutral to its 2017 earnings per share and to be accretive thereafter. Financial terms of the transaction were not undisclosed.

$HSIC {{ '2017-09-18T13:34:28+0000' | timeago}} • Announcement

The BoD of $HSIC has authorized repurchase of up to $400MM of shares of the company's common stock. This is further to the $400MM repurchase program announced in Oct 2016. The firm had approx 158MM shares outstanding as on Sept 15, 2017 and the new authorization represents approx 3% of shares outstanding at current stock price.

$HSIC {{ '2017-08-28T20:15:13+0000' | timeago}} • Announcement

$HSIC agreed to buy Merritt Veterinary Supplies, Inc., an independent, family-owned supplier of animal health products, for undisclosed terms. $HSIC expects the acquisition to be neutral to its 2017 EPS and to be accretive thereafter. Upon the closing, which is expected in 3Q17, Merritt will become part of Henry Schein Animal Health.

$HSIC {{ '2017-08-16T16:54:10+0000' | timeago}} • Announcement

$HSIC's division Henry Schein Dental entered into an agreement with CAEK, Inc., a Software-as-a-Service company, to purchase CAEK’s HIPAA software, LayerCompliance. LayerCompliance helps healthcare practitioners navigate the requirements of the Health Insurance Portability and Accountability Act.

$HSIC {{ '2017-08-16T12:48:15+0000' | timeago}} • Announcement

The BoD of $HSIC has given nod for a 2-for-1 split of the company's common stock. Each Henry Schein stockholder of record as on Sept 1, 2017, will receive a dividend of one additional share for every share held, and trading will begin on a split-adjusted basis on Sept 15, 2017. Following the split, $HSIC will have approx. 158MM shares outstanding.

$HSIC {{ '2017-06-28T12:03:39+0000' | timeago}} • Announcement

$HSIC extended its existing agreement in Canada with $XRAY to include the CEREC CAD/CAM restoration system and the Schick line of imaging sensors. Henry Schein Canada will represent the entire $XRAY product line, effective Sept. 1, 2017. The revised agreement is expected to be neutral to $HSIC EPS in 2017 and accretive thereafter.

$HSIC {{ '2017-06-27T20:45:25+0000' | timeago}} • Announcement

$HSIC settled litigation with SourceOne Dental Inc. that will result in a $0.04 per share charge when the company reports its 2Q17 results. The company denies any wrongdoing related to the SourceOne litigation and chose to pursue a settlement solely to avoid further distraction and cost resulting from this matter.

$HSIC {{ '2017-05-09T15:05:15+0000' | timeago}} • Webcast

$HSIC believes the market for implants is growing strongly throughout the world. Implants grew mid-single digits worldwide with good growth in the US. Europe is a bit muted while the developing world is growing significantly. The investments by specialists in digital technology is driving equipment sales throughout the world.

$HSIC {{ '2017-05-09T14:52:21+0000' | timeago}} • Webcast

$HSIC does not see much change in its go-to-market strategy. The company has been building its digital technology and capacity for the last 4-5 years. The goal is to provide the best comprehensive solution to dentists. $HSIC has invested heavily in its practice solutions software. $HSIC will continue to add more resources and expand its offerings.

$HSIC {{ '2017-05-09T12:18:37+0000' | timeago}} • Announcement

$HSIC afffirmed its 2017 EPS guidance of $7.17-7.30. This guidance reflects growth of 16-18% compared with 2016 EPS of $6.19, and growth of 8-10% compared with 2016 non-GAAP EPS of $6.61. The company noted that FY17 includes one less week than FY16.

$HSIC {{ '2017-05-09T12:16:27+0000' | timeago}} • Announcement

$HSIC reported a rise in 1Q17 earnings driven by higher sales. Net income rose to $140.75MM or $1.76 per share from $113.75MM or $1.37 per share last year. Net sales grew to $2.92Bil from $2.71Bil, on 8.7% growth in local currencies and a 1.0% decline related to foreign currency exchange.

$XRAY {{ '2017-05-09T11:11:53+0000' | timeago}} • Announcement

$XRAY announced a new distribution agreement with $PDCO, continuing its partnership over many years. Additionally, $XRAY announced a new three-year agreement with $HSIC, effective September 1, 2017 to distribute $XRAY's full line of dental equipment in the US.

$HSIC {{ '2017-05-02T14:40:25+0000' | timeago}} • Announcement

$HSIC, a provider of health care products and services, has completed its acquisition of Southern Anesthesia Surgical, a distributor of anesthesia and surgical supplies. The transaction was announced on February 20, 2017. Financial terms of the transaction were not disclosed.

Recent Transcripts

IMUC (ImmunoCellular Therapeutics, Ltd.)
Tuesday, November 21 2017 - 10:00pm
PDCO (Patterson Companies, Inc.)
Tuesday, November 21 2017 - 3:00pm
TRXC (TransEnterix, Inc.)
Thursday, November 9 2017 - 9:30pm
HOLX (Hologic Inc.)
Wednesday, November 8 2017 - 9:30pm
HUM (Humana Inc.)
Wednesday, November 8 2017 - 2:00pm
ZIOP (ZIOPHARM Oncology, Inc.)
Monday, November 6 2017 - 9:30pm
HSIC (Henry Schein, Inc.)
Monday, November 6 2017 - 3:00pm
CAH (Cardinal Health, Inc.)
Monday, November 6 2017 - 1:30pm
TXMD (TherapeuticsMD, Inc.)
Monday, November 6 2017 - 1:00pm
PLUS (ePlus inc.)
Thursday, November 2 2017 - 8:30pm
ARW (Arrow Electronics, Inc.)
Thursday, November 2 2017 - 5:00pm
HSKA (Heska Corporation)
Thursday, November 2 2017 - 3:00pm
USPH (US Physical Therapy Inc.)
Thursday, November 2 2017 - 2:30pm
ABC (AmerisourceBergen Corporation)
Thursday, November 2 2017 - 12:30pm
SYN (Synthetic Biologics Inc.)
Wednesday, November 1 2017 - 8:30pm
STE (Steris Plc)
Wednesday, November 1 2017 - 2:00pm
AGN (Allergan plc)
Wednesday, November 1 2017 - 12:30pm
OMI (Owens & Minor Inc.)
Wednesday, November 1 2017 - 12:00pm
WCG (WellCare Health Plans, Inc.)
Tuesday, October 31 2017 - 1:30pm
AET (Aetna Inc.)
Tuesday, October 31 2017 - 12:30pm

AlphaGraphics you may like